Zoetis Hits New 52-Week High at $33.69 (ZTS)
Zoetis (NYSE:ZTS)’s share price hit a new 52-week high on Friday , ARN reports. The company traded as high as $33.69 and last traded at $33.51, with a volume of 2,267,011 shares. The stock had previously closed at $33.07.
Several analysts have recently commented on the stock. Analysts at Jefferies Group cut their price target on shares of Zoetis from $38.00 to $37.00 in a research note on Monday. They now have a “buy” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Zoetis in a research note on Wednesday, August 6th. They now have a $34.00 price target on the stock. Finally, analysts at BMO Capital Markets cut their price target on shares of Zoetis from $37.00 to $36.00 in a research note on Wednesday, August 6th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $29.80.
The stock has a 50-day moving average of $32.62 and a 200-day moving average of $30.93. The company has a market cap of $16.847 billion and a P/E ratio of 31.50.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, September 2nd. Stockholders of record on Wednesday, August 20th will be given a dividend of $0.072 per share. This represents a $0.29 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date of this dividend is Monday, August 18th.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.